Novel Ruthenacarborane–NSAID Conjugates
The significant side effects associated with platinum-based anticancer agents have driven the continuous pursuit of novel, non-platinum-based metal compounds. Ruthenium-based organometallic compounds have emerged as promising alternatives, owing to their distinctive and adaptable biochemical propert...
保存先:
| 主要な著者: | , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2025-10-01
|
| シリーズ: | Molecules |
| 主題: | |
| オンライン・アクセス: | https://www.mdpi.com/1420-3049/30/21/4153 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
